This Month in the Journal  by Ashkenas, John
Am. J. Hum. Genet. 63:i–ii, 1998
i
This Month in the Journal
This month we present a series of reviews on ethical
issues that have been raised among human geneticists
and the lay public. Reilly (p. 682) recounts the historical
abuse of subjects by the medical community and the rise
of institutional review boards, and he comments on the
proposed guidelines for working with indigenous com-
munities that Foster et al. (p. 696) developed in their
work with the Apache Nation. Claims of community
rights, which Foster and his colleagues presuppose, have
been made only recently, and concern for notions such
as the right of a group to prevent the study of its ge-
notype is nearly nonexistent in institutional policy.
Juengst (p. 673) argues that the appeal to community
rights, which might conflict with or even supersede the
rights of individuals, should be rejected, because these
rights are based on a biologically naive definition of
“community.” We (Byers and Ashkenas; p. 678) discuss
the issues of privacy that surround the publication of
pedigrees in research papers. Finally, Knoppers (p. 686)
considers the claims, discussed by Mao (p. 688), that
the present-day medical policy in China is tantamount
to eugenics.
Mutations in Opitz Syndrome, by Gaudenz et al.
(p. 703)
Midline defects have been identified in many organisms.
Opitz syndrome, one of several recognized midline-de-
fect diseases in humans, is associated with mutations in
the X-linked MID1 gene. The MID1 gene product is a
RING-finger protein that is believed to interact with
multiple partner proteins to form a large complex, prob-
ably within the nucleus. In their article, Gaudenz and
colleagues describe the genomic structure ofMID1, and
they report six novel mutations that they have identified
by SSCP and direct sequence analysis. All but one of the
nine published disease alleles in MID1 affect the C-ter-
minal domain, which is highly conserved among RING/
B-box proteins but which has no known function. The
authors note that, although they were able to identify
mutations in more than a third of the familial cases of
Opitz syndrome, only 1 of 18 apparent sporadic cases
carried identifiable mutations.
Parental Origin of the Achondroplasia Mutation, by
Wilkin et al. (p. 711)
G1138 of the growth-factor–receptor gene FGFR3 may
be the most mutable nucleotide in the human genome.
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This base occurs in a CpG dinucleotide, but its rate of
mutation is at least two orders of magnitude greater than
the average value for CpG sequences, and it is subject
to both transitions and transversions. These two classes
of mutation cause an identical amino acid substitution
and lead to a common autosomal dominant growth dis-
order, achondroplasia. Because the risk of sporadic
achondroplasia increases with paternal age, the FGFR3
defect long has been supposed to arise in the male germ
line. Wilkin et al. used a set of novel single–base-pair
polymorphisms in this gene to determine the phase of
the G1138A mutation in a large set of sporadic cases.
They report that the mutation occurred on the paternally
derived allele in each of 40 informative cases. Because
achondroplasia is seldom seen in more than one child
of unaffected parents, germ-line mosaicism seems un-
likely, and the authors conclude that de novo mutations
occur during spermatogenesis but rarely, if ever, during
oogenesis.
Deletions in Epidermolysis Bullosa, by Sakuntabhai
et al. (p. 737)
Blistering diseases can arise from defects in the extra-
cellular-matrix components that link the dermal and ep-
idermal layers of the skin. One such disorder, dystrophic
epidermolysis bullosa, results frommutations in the type
VII collagen gene, COL7A1. As with other collagen de-
fects, severe, dominantly acting mutations would be ex-
pected when in-frame deletions or insertions make it
impossible for the product of the mutant allele to align
with the wild-type chains, during molecular assembly.
Sakuntabhai and coworkers now report two such mu-
tations—namely, short genomic deletions that occur
within exons and that, surprisingly, cause the affected
exon to be skipped. The deletions, which cause in-frame
deletions in the mRNA sequence, may act by removing
exonic splicing enhancers or by reducing the length of
the exons so that they are recognized inefficiently by the
splicing machinery. The products of the improperly
spliced mRNAs cause procollagen molecules to accu-
mulate within the cell, and they prevent normal depo-
sition of anchoring fibrils below the dermal-epidermal
boundary.
Genetic Testing of Young Colon Cancer Patients, by
Farrington et al. (p. 749)
hMSH2 and hMLH1 encode two components of the
DNA-mismatch–repair system and commonly are mu-
tated in families with hereditary nonpolyposis colorectal
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cancer (HNPPC). Indeed, half of all HNPPC probands
who fulfill strict criteria for family history of the disease
carry a mutation in one of these two genes. Farrington
and coworkers suggest, however, that the carrier fre-
quency for mutations may be higher than that indicated
by the frequency of such cancer-prone families. The au-
thors screened for mutations in constitutional tissue
from individuals who were diagnosed with colorectal
cancer at age !30 years. This stringently selected group
displayed microsatellite instability at an unusually high
rate, compared with that among other colorectal cancer
patients, and more than a third of these individuals carry
hMSH2 or hMLH1 sequence variants that are likely to
be pathogenic. Family history proves to be a poor
predictor of germ-line mutation status among these
individuals.
Mapping Osteosarcoma and Paget Disease, by
Nellissery et al. (p. 817)
Bone fragility and excess resorption, as well as over-
growth of osteoblasts, are hallmarks of both osteosar-
coma and, in a milder form, Paget disease of the bone.
Paget disease is a common precursor to osteosarcoma,
predicting both which individuals in an affected family
and which bones in that individual are at risk for de-
velopment of osteosarcoma. Both Paget disease and a
similar autosomal dominant condition, familial expan-
sile osteolysis, have been mapped to 18q. Nellissery et
al. propose that osteosarcomas could arise from pagetic
tissue by loss of heterozygosity (LOH) at this same locus.
In their article, they report multiple independent oste-
osarcomas that have undergone mitotic recombination
leading to LOH in 18q. The minimal region of LOH
defined by these somatic events may help restrict the
critical region for Paget disease.
LOD-Score Analyses in Complex Disease, by
Greenberg et al. (p. 870)
Greenberg et al. have argued that linkage analysis can
proceed even without an accurate model for the mode
of transmission of a trait. In an earlier paper, they rec-
ommended analyzing the likelihood of linkage, under
just two models—one dominant and the other reces-
sive—and accepting the results of whichever model
yields the higher LOD scores. They showed that, even
when complex models were used to generate simulated
family data, analysis based on one or the other of these
simple models could reliably detect linkage with only a
modest reduction of the peak LOD score, relative to
analysis under the true model that had generated the
data. These authors now revisit this approach, to con-
sider the loss of statistical power that results from anal-
ysis under the simple, rather than the true, model. In
general, power loss is !20%, suggesting that simple
models might be useful when the mode of inheritance
cannot be specified in advance. However, when power
is low even for analysis under the true model, the power
loss is proportionally greater, and, so, the simplified
models may be inadequate to identify linkage. Thus, for
a data set in which the effects of a single locus predom-
inate, the additive effects of a minor locus may not be
detected consistently, unless the mode of inheritance is
known in advance and can be built into the analytic
model.
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